TOU-T -0.48 PPL-T 0.43 ZLU.U-T 0.13 XMU-T -0.11 VGG-T -0.02 WOLF-N -0.43
Nicholas Sargen

Nicholas Sargen

Chief Investment Officer at Fort Washington Investment Advisors

Member since: Mar '04 · 22 Opinions

UnlockRating

Rating Card

premiumPremium content

Unlock Expert's Rating and Top Picks Portfolio

Curated by Michael O'Reilly since 2020
1550+ opinions with 4.81 rating (one of the best performing expert)

Latest Top Picks

Unlock Nicholas's portfolio

Stock Opinions by Nicholas Sargen

TOP PICK

Procter & Gamble(PG-N)

Nov 26, 2004
Feels there will be a rotation to larger caps in the US. An innovative firm.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$53.640

Stock price when the opinion was issued

misc consumer products
TOP PICK

Coca-Cola Company(KO-N)

Nov 26, 2004
Feels there will be a rotation to larger caps in the US. Has lagged, but has about 70% exposure to the offshore market.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$39.860

Stock price when the opinion was issued

food processing
TOP PICK

Alere Inc(ALR-N)

Oct 15, 2004
A very dynamic management team. Has the potential over the long run to be very successful.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$19.740

Stock price when the opinion was issued

Consumer Products
TOP PICK

Sealed Air Corp(SEE-N)

Oct 15, 2004
Terrific management. Hasn't been doing a lot, but over the long term an excellent story.
Nicholas SargenNicholas Sargen
No
Unlock Rating
$45.550

Stock price when the opinion was issued

packaging containers
TOP PICK

Pfizer Inc(PFE-N)

Sep 24, 2004
Best value in the market is in quality names. Best pharmaceutical company in the world. Just hasn't gone anywhere. New products are going into the pipeline.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$29.660

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Bank of New York Mellon(BK-N)

Sep 24, 2004
Best value in the market is in quality names. Less sensitive to interest rates. Attractively priced.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$30.020

Stock price when the opinion was issued

Financial Services
TOP PICK

Comcast Corp(CMCSA-Q)

Sep 24, 2004
Best value in the market is in quality names. Well positioned with surplus cash.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$28.140

Stock price when the opinion was issued

Cable
TOP PICK

Deere & Co.(DE-N)

Aug 13, 2004
Likes the industrial space. The first leg of the expansion has been in smaller size tractors. Expects this will move to heavier duty/higher-margin equipment.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$59.380

Stock price when the opinion was issued

machinery
TOP PICK

Union Pacific Corp(UNP-N)

Aug 13, 2004

(Top Sell) Has had a good run but with a rising interest rate environment it will tend to underperform.

Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$55.240

Stock price when the opinion was issued

Transportation
TOP PICK

Amgen Inc.(AMGN-Q)

Aug 13, 2004
Likes the health-care sector. One of the top companies. Has underperformed for a long time, but they are willing to be patient.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$54.360

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Medtronic Inc(MDT-N)

Jul 02, 2004
Solid earnings. Feels their new stent will be successful next year.
Nicholas SargenNicholas Sargen
Unknown
Unlock Rating
$49.620

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Comcast Corp(CMCSA-Q)

Jul 02, 2004
Made a lot of capital outlays. Generating big cash flows. Stock is under appreciated.
Nicholas SargenNicholas Sargen
Unknown
Unlock Rating
$27.960

Stock price when the opinion was issued

Cable
TOP PICK

Intel(INTC-Q)

May 14, 2004
A premier name. Has sold off significantly.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$27.050

Stock price when the opinion was issued

computer parts mnfctr
TOP PICK

Amgen Inc.(AMGN-Q)

May 14, 2004
Health care should outperform in a rising interest rate environment. A premier company. Likes the pipeline that it has. Out-of-favor right now.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$56.650

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Radian Group Inc(RDN-N)

May 14, 2004
A more controversial sector at this time is financials. With job creation, people will be able to pay their mortgages.
Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$45.300

Stock price when the opinion was issued

finance leasing
Showing 1 to 15 of 22 entries
Next PageNext Page

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

SPB-T 0.06$8.2
OR-T 0.19$36.63
AI-T 0.1$11.44
CVE-T -0.17$19.64
ATD-T 0.25$69.66

Today's Top Picks

TOU-T -0.48$62.77
PPL-T 0.43$50.34
ZLU.U-… 0.13$41.34
XMU-T -0.11$85.87
VGG-T -0.02$96.41

Popular Articles

Latest Sell Signals

ALA-T 0.5$39.03
BN-T 1.74$87.35
SLF-T 0.47$84.77
MFC-T 0.26$41.99
CTC.A-… -0.29$188.76

Most Recent Experts

Bill Harris, CFA

Bill Harris, CFA

Avenue Investment Management

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Bruce Campbell (2)

Bruce Campbell (2)

Stone Castle Investment Management Inc.

Stockchase Insights

Stockchase Insights

5i Research

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica